跳至主要内容
临床试验/NCT07113431
NCT07113431已完成不适用

A Novel Partial-enteral Nutrition Protocol to Improve Nutrition Status of Adults Patients Experiencing a Crohn's Disease Flare and Starting New Immunologic Therapy.

Kate Farms Inc1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Nutrient intake

研究概览

简要总结

A novel dietary intervention combining a standardized IBD diet (IBD-AID) with supplementation from a pea protein plant-based oral nutrition supplement (ONS) (Kate Farms Peptide 1.5) to improve protein, calorie, and nutrient intake in adult patients experiencing a Crohn's disease flare starting new immunologic therapy. Additionally, this study will include objective measures of body composition to improve nutrition status assessment and provide a more sensitive measure of intervention efficacy compared to anthropometric measures of body weight or BMI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Moderate to severe CD as defined by physician and starting new biologic therapy
  • •Able and willing to complete the study procedures
  • •Age > 18
  • •Able to comply with study measures in the opinion of the investigator

排除标准

  • •Diagnosis of short bowel syndrome
  • •Presence of ileostomy or colostomy
  • •Presence of a pacemaker or any electronic implantable device
  • •Use of pre or probiotic supplements within 14 days of randomization
  • •High risk for development of refeeding syndrome
  • •In the opinion of the investigator would not complete the study procedures
  • •Patients with active implanted medical devices, e.g. cardiac pacemakers, defibrillators or patients connected to electronic life support devices
  • •Pregnant Patients: while the use of bioimpedance technology in pregnant patients has been shown to have no adverse effects, it has yet to be clinically validated for use with that population group
  • •Serious, concomitant illness that, in the opinion of the investigator would interfere with evaluation of safety or efficacy, or put the participant at risk of harm from study participation

研究组 & 干预措施

IBD-AID diet

Placebo Comparator

干预措施: IBD-AID diet (Other)

IBD-AID Diet + Kate Farms Peptide 1.5

Active Comparator

干预措施: IBD-AID diet combined with Kate Farms Peptide 1.5 (Dietary Supplement)

结局指标

主要结局

Nutrient intake

时间窗: 8 weeks

Nutrient intake improvement assessed by 24-hour dietary recall from a combined intervention of a standard IBD-AID diet with an oral nutrition supplement drink (Kate Farms Peptide 1.5) compared to a standard diet alone without an oral nutrition supplement drink.

次要结局

  • Body composition(8 weeks)

研究者

发起方
Kate Farms Inc
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验